Actively Recruiting
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Led by Stanford University · Updated on 2025-12-24
9999
Participants Needed
1
Research Sites
5217 weeks
Total Duration
On this page
Sponsors
S
Stanford University
Lead Sponsor
T
The Leukemia and Lymphoma Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
CONDITIONS
Official Title
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade
- Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea)
- A routine procedure for tissue collection is planned
- Ability to understand and the willingness to sign a written informed consent
You will not qualify if you...
- Patients without NHL or Hodgkin's disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stanford University School of Medicine
Stanford, California, United States, 94305
Actively Recruiting
Research Team
A
Alyssa M Kanegai
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here